Michail Rallis

Prof. Michail Rallis

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2023 in Separations
Verified
Journal Article
Open access
PDF file
EGEugenia Ganosi
Eugenia Ganosi
Christina BardaChristina Barda
Christina Barda
MGMaria-Eleni Grafakou
Maria-Eleni Grafakou
MRMichail Rallis
Michail Rallis
HSHelen D. Skaltsa
Helen D. Skaltsa
In recent years, there has been a growing scientific interest in essential oils due to their therapeutic and aromatic properties and as potential alternative natural additives for use as preservatives or antibiotics. However, the literature lacks a comprehensive understanding of their stability and how their composition and properties change over time under various conditions. Through this paper, we aim to enhance the existing literature by providing deeper insights into the stability of essential oils and the sustainability of chemical composition in a time-based approach under various conditions. Therefore, four essential oils of the Lamiaceae family (Origanum vulgare, Thymus vulgaris, Mentha spicata, and M. x piperita) were evaluated with respect to their chemical variation influenced by several factors, such as thermal and storage conditions. Three types of containers were utilized to store the essential oils, i.e., glass ampoules, glass tubes, and metallic containers with plastic caps, for up to six months in −20 °C, 4 °C, 23 °C (with or without light exposure), 35 °C, and 45 °C. Samples were routinely analyzed by GC-MS and components were subjected to principal component analysis to ascertain whether the identified constituents may be useful in reflecting the stability of the analyzed samples. The main compounds appeared to be more stable, while the degradation of minor constituents (<1.0%) occurred in all four essential oils despite the storage conditions. Overall, apart from a slight variation in the chemical load, essential oils can be considered stable for various applications, especially those stored under low oxygen availability conditions.

18 October 2023 in Annals of Biomedical Engineering
Verified
Journal Article
Open access
PDF file
EMEvdoxia Mathioudaki
Evdoxia Mathioudaki
MRMichail Rallis
Michail Rallis
KPKonstantinos Politopoulos
Konstantinos Politopoulos
EAEleni Alexandratou
Eleni Alexandratou
This study aims to investigate the effectiveness of low power red light (661 nm) in accelerating the wound healing process of an in vitro scratch assay model of keratinocytes. Furthermore, the study aims to clarify the role of light irradiation parameters, optimize them and gain additional insight into the mechanisms of wound closure as a result of photobiomodulation. Wound healing was studied using scratch assay model of NCTC 2544 keratinocytes. Cells were irradiated with a laser at various power densities and times. Images were acquired at 0, 24, 48 and 72 h following the laser treatment. Cellular proliferation was studied by MTT. ROS were studied at 0 and 24 h by fluorescence microscopy. Image analysis was used to determine the wound closure rates and quantify ROS. The energy range of 0.18–7.2 J/cm2 was not phototoxic, increased cell viability and promoted wound healing. Power and irradiation time proved to be more important than energy. The results indicated the existence of two thresholds in both power and irradiation time that need to be overcome to improve wound healing. An increase in ROS production was observed at 0 h only in the group with the lowest healing rate. This early response seemed to block proliferation and finally wound healing. Low level laser light at 661 nm enhanced both proliferation and migration in keratinocytes, providing evidence that it could possibly stimulate wound healing in vivo. The observed results are dependent on irradiance and irradiation time rather than energy dose in total.

26 August 2022 in Marine Drugs
Verified
Journal Article
Open access
PDF file
SKStefanos Kikionis
Stefanos Kikionis
MKMarianna Koromvoki
Marianna Koromvoki
ATANNA TAGKA
ANNA TAGKA
EPEleni Polichronaki
Eleni Polichronaki
ASAlexandros Stratigos
Alexandros Stratigos
Vassilios RoussisVassilios Roussis
Vassilios Roussis
Keloids are skin fibroproliferative disorders, resulting from abnormal healing of deep cutaneous injuries. Cryosurgery, the most common treatment for keloids, causes skin traumas. Even though the clinical practice of cryosurgery has increased, effective wound healing therapy is still lacking. In this investigation, nonwoven nanofibrous patches composed of ulvan, a marine sulfated polysaccharide exhibiting anti-inflammatory and antioxidant activities, and polyethylene oxide (PEO) were fabricated through electrospinning and characterized. Their wound healing efficacy on skin traumas resulting from cryosurgical treatment of keloids was clinically tested and evaluated in comparison to a reference product. Twenty-four volunteer patients undergoing cryosurgery as a treatment of keloids were selected to apply either the ulvan/PEO patch or the reference product for 21 days. The ulvan/PEO patch, 21 days after cryosurgery, showed significant wound healing, elimination of skin inflammation, restoration of biophysical parameters similar to normal values and significant decrease in haemoglobin concentration, skin texture and volume, while no discomfort or adverse reaction was observed. In contrast, the reference product showed inferior performance in all evaluated parameters. The designed ulvan/PEO patch represents the first wound dressing to effectively heal skin trauma after cryosurgical treatment of keloids.

21 June 2022 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
ATAsimina Terezaki
Asimina Terezaki
SKStefanos Kikionis
Stefanos Kikionis
Efstathia IoannouEfstathia Ioannou
Efstathia Ioannou
ISIoannis Sfiniadakis
Ioannis Sfiniadakis
Leto-Aikaterini TzivelekaLeto-Aikaterini Tziveleka
Leto-Aikaterini Tziveleka
MRMichail Rallis
Michail Rallis

1 January 2020 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
DDDimas Dimitris
Dimas Dimitris
Ekaterina-Michaela TomouEkaterina-Michaela Tomou
Ekaterina-Michaela Tomou
KCKaramani Christina
Karamani Christina
ISIOANNIS SFINIADAKIS
IOANNIS SFINIADAKIS
SISiakavella K. Ioanna
Siakavella K. Ioanna
HSHelen D. Skaltsa
Helen D. Skaltsa

26 May 2021 in Cancers
Verified
Journal Article
Open access
PDF file
Aikaterini KyritsiAikaterini Kyritsi
Aikaterini Kyritsi
SKStefanos Kikionis
Stefanos Kikionis
ATAnna Tagka
Anna Tagka
NKNikolaos Koliarakis
Nikolaos Koliarakis
AEAntonia Evangelatou
Antonia Evangelatou
MRMichail Rallis
Michail Rallis
Acute radiodermatitis is the most common side effect in non-melanoma skin cancer patients undergoing radiotherapy. Nonetheless, despite the ongoing progress of clinical trials, no effective regimen has been found yet. In this study, a non-woven patch, comprised of electrospun polymeric micro/nanofibers loaded with an aqueous extract of Pinus halepensis bark (PHBE), was fabricated and clinically tested for its efficacy to prevent radiodermatitis. The bioactivity of the PHBE patch was evaluated in comparison with a medical cream indicated for acute radiodermatitis. Twelve volunteer patients were selected and randomly assigned to two groups, applying either the PHBE patch or the reference cream daily. Evaluation of radiation-induced skin reactions was performed during the radiotherapy period and 1 month afterwards according to the Radiation Therapy Oncology Group (RTOG) grading scale, photo-documentation, patient-reported outcomes (Visual Analog Scale, questionnaire), biophysical measurements (hydration, transepidermal water loss, erythema, melanin), and image analysis. In contrast with the reference product, the PHBE patch showed significant anti-inflammatory activity and restored most skin parameters to normal levels 1 month after completion of radiation therapy. No adverse event was reported, indicating that the application of the PHBE patch can be considered as a safe medical device for prophylactic radiodermatitis treatment.